Press Release Oncomatryx Biopharma, a biotechnology company pioneering next-generation Antibody-Drug Conjugates (ADCs) for oncology, has been awarded funding from the European Innovation Council (EIC) ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Skin health experts debunk collagen myths, like whether or not collagen supplements really work, and all the ways you can ...

This new article publication from Acta Pharmaceutica Sinica B, discusses a high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal ...

Actithera A/S is poised to bring small-molecule pharmacokinetics to radiopharmaceuticals after closing a $75.5 million series A that will fund initial clinical development of a candidate targeting the ...

This new article publication from Acta Pharmaceutica Sinica B, discusses a high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced an oral presentation ...

Peptides have emerged as a fascinating area of scientific inquiry due to their potential to modulate various physiological ...

GFAP, or glial fibrillary acidic protein, supports star-shaped brain cells called astrocytes that help maintain nerve cell ...

Scientists have discovered that a protein once thought to be just a cellular "courier" actually helps plants survive drought. This motor protein, myosin XI, plays a critical role in helping leaves ...

Could psychedelics be the next frontier in longevity research? Early data show psilocybin delays aging in lab tests.